Home » Topics » BioWorld Science

BioWorld Science
RSS

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

PharmaMar describes HER2-targeting antibody-drug conjugates

Nov. 12, 2021

Calreticulin as promising new therapeutic target in breast cancer

Nov. 12, 2021

SCO-spondin-derived peptide shows neuroprotection and increased synaptic transmission in the CNS

Nov. 12, 2021

FPR2 agonist NAP-1051 shows promise in preclinical SLE model

Nov. 12, 2021

Ascentage Pharma polycomb protein EED inhibitor displays potency, tumor regression potential

Nov. 12, 2021

Biomea Fusion advances BMF-219 for leukemia

Nov. 11, 2021

BACH1 targeting has neuroprotective effects in Parkinson's disease

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...